| Financial Year |
March 31 2023 |
| Monetary Funds |
1,030,664,121.36 |
| Held-for-trading Financial Assets |
18,113,870.87 |
| Notes Receivable |
170,836,427.89 |
| Accounts Receivable |
4,347,179,723.83 |
| Advances to Suppliers |
222,016,599.74 |
| Other Receivables |
464,360,462.68 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,387,972,207.40 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
39,951,107.54 |
| Other Current Assets |
697,675,851.46 |
| Total Current Assets |
8,791,669,320.06 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
278,738,354.89 |
| Investment Properties |
-- |
| Fixed Assetes |
7,148,919,937.45 |
| Under-construction Projects |
2,484,647,895.27 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
540,151,239.64 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
175,918,146.63 |
| Deferred Income Tax Assets |
161,480,799.57 |
| Other Non-Current Assets |
785,323,322.45 |
| Sub-Total of Non-Current Assets |
11,720,670,265.64 |
| Total Assets |
20,512,339,585.70 |
| Short-Term Loans |
2,896,112,805.54 |
| Trading Financial liabilities |
-- |
| Notes Payable |
403,600,034.11 |
| Accounts Payable |
2,221,157,073.40 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
32,209,621.34 |
| Taxes Payable |
83,332,863.28 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
47,116,183.30 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
984,970,704.54 |
| Other Current Liabilities |
28,630,973.73 |
| Sub-Total of Current Liabilities |
6,939,839,258.71 |
| Long-term Loans |
4,393,808,953.12 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
782,153,012.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
16,773,144.35 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
5,256,845,923.23 |
| Total Liabilities |
12,196,685,181.94 |
| Paid-In Capital(Or Share Stock) |
1,802,509,062.00 |
| Capital Surplus |
1,678,283,137.00 |
| Surplus Reserve |
422,894,574.73 |
| LESS:Treasury Stock |
26,664,006.67 |
| Undistributed Profits |
4,374,887,827.92 |
| Minority Stockholder's Interest |
63,048,397.72 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
8,252,606,006.04 |
| Owner's Equity（Stockholder's Equity） |
8,315,654,403.76 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
20,512,339,585.70 |
